Stuart Poulton - 18 Feb 2025 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Signature
/s/Nancy Smith as Attorney-in-Fact for Stuart Poulton
Issuer symbol
KPTI
Transactions as of
18 Feb 2025
Net transactions value
-$3,726
Form type
4
Filing time
19 Feb 2025, 16:17:36 UTC
Previous filing
31 Jul 2024
Next filing
04 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $3,726 -5,914 -1.8% $0.6300 320,714 18 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.